Inventor
MORI TOSHIYUKI
JP51 patents
⚠️ This page may combine multiple inventors who share the name “MORI TOSHIYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YAZAKI CORP
7 patentsUS6272746B1Aug 14, 2001
Circuit body and process for producing the circuit body
YAZAKI CORP18 citations84
US6385845B2May 14, 2002
Wiring structure and method for wiring electrical wire on base member
YAZAKI CORP6 citations74
US6225561B1May 1, 2001
Wiring structure and method for wiring electrical wire on base member
YAZAKI CORP13 citations74
US5980296ANov 9, 1999
Connecting structure for flat circuit body and connector
YAZAKI CORP9 citations74
US5945637AAug 31, 1999
Terminal attachment structure having a cradle portion to prevent tottering of the terminal
YAZAKI CORP7 citations74
US6172308B1Jan 9, 2001
Terminal for circuit assembly having a cradle portion to prevent tottering of the terminal
YAZAKI CORP4 citations63
US6310302B1Oct 30, 2001
Wiring structure of wire and wiring method
YAZAKI CORP1 citations52
MATSUDA MAMORU
7 patentsUS8551991B2Oct 8, 2013
1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
MATSUDA MAMORU3 citations61
US8193187B2Jun 5, 2012
1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity
MATSUDA MAMORU3 citations60
US8580784B2Nov 12, 2013
Method for treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8569493B2Oct 29, 2013
Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
MATSUDA MAMORU1 citations50
US8563551B2Oct 22, 2013
Method for preventing or treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8440660B2May 14, 2013
Method for treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8420635B2Apr 16, 2013
Method for preventing or treating a glucocorticoid receptor-related disease
MATSUDA MAMORU0 citations50
TOSOH CORP
5 patentsUS5665482ASep 9, 1997
Fluorite structure type ceria type solid electrolyte
TOSOH CORP19 citations92
US5017530AMay 21, 1991
Silicon nitride sintered body and process for preparation thereof
TOSOH CORP9 citations73
US5204077AApr 20, 1993
Pollucite crystalline powders with low thermal expansion coefficients and methods for their preparation
TOSOH CORP10 citations72
US5032556AJul 16, 1991
Preparation method for zircon powder
TOSOH CORP17 citations72
US5250480AOct 5, 1993
Method for preparing zircon powder
TOSOH CORP2 citations57
SANTEN PHARMACEUTICAL CO LTD
5 patentsUS8017775B2Sep 13, 2011
1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
SANTEN PHARMACEUTICAL CO LTD3 citations61
US8008498B2Aug 30, 2011
1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD1 citations61
US8975256B2Mar 10, 2015
1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity
SANTEN PHARMACEUTICAL CO LTD0 citations51
US8008496B2Aug 30, 2011
1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD0 citations51
US8008497B2Aug 30, 2011
1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD0 citations51
US HEALTH
4 patentsUS7884178B2Feb 8, 2011
Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
US HEALTH9 citations84
US7553936B2Jun 30, 2009
Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
US HEALTH10 citations75
US6780847B2Aug 24, 2004
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US HEALTH7 citations71
US7339037B2Mar 4, 2008
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US HEALTH3 citations60
KANEKA CORP
4 patentsUS7105602B1Sep 12, 2006
Processing aid for thermoplastic resin and thermoplastic resin composition containing the same
KANEKA CORP13 citations82
US6765033B1Jul 20, 2004
Expandable vinyl chloride resin composition
KANEKA CORP13 citations82
US6747083B2Jun 8, 2004
Process for producing rubber latex containing water in particle
KANEKA CORP6 citations70
US6605672B1Aug 12, 2003
Impact modifiers for thermoplastic resins
KANEKA CORP6 citations60
DISCO ABRASIVE SYSTEMS LTD
2 patentsTOSO KK
2 patentsNAT INST RES INORGANIC MAT
2 patentsKATO MASATOMO
2 patentsUS8664221B2Mar 4, 2014
Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent
KATO MASATOMO2 citations56
US8426406B2Apr 23, 2013
Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group
KATO MASATOMO2 citations53
SMC KK
1 patentNEKTAR THERAPEUTICS AL
1 patentBOYD MICHAEL R
1 patentO'KEEFE BARRY
1 patentKANEGAFUCHI CHEMICAL IND
1 patentCENTRAL NIPPON EXPRESSWAY COMPANY LTD
1 patentHONDA MOTOR CO LTD
1 patentOLYMPUS CORP
1 patentNEKTAR THERAPEUTICS AL CORP
1 patentNAT INST FOR MATERIALS SCIENCE
1 patentShowing the top 50 of 51 patents by PatentIndex Score.